Stocks
Genprex, Inc.GNPX
NASDAQHealthcareBiotechnology$2.01+2.55%
Price as of · delayed, not real-time
Focused on developing gene therapies for cancer and diabetes, this clinical-stage biopharmaceutical company is known for its lead candidate, Reqorsa Immunogene Therapy. Investors monitor its progress due to its potential in addressing unmet medical needs and its micro-cap volatility.
Market Cap: $3.3M52W Range: $1.71 – $55.00
Congressional Interest in Genprex, Inc. (GNPX)
1 member of Congress has disclosed 3 trades in Genprex, Inc. (GNPX), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
3
Unique Politicians
1
Buys
3
Sells
0